Syndecan-1 in breast cancer stroma fibroblasts regulates extracellular matrix fiber organization and carcinoma cell motility

American Journal of Pathology

Volumn 178, Issue 1, 2011, Pages 325-335

  Yang, Ning ^a   Mosher, Rachel ^b   Seo, Songwon ^c   Beebe, David ^b   Friedl, Andreas ^a,d  

^a University of Wisconsin Health   (United States)

^b University of Wisconsin Madison   (United States)

^c UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^d WILLIAM S MIDDLETON MEMORIAL VETERANS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SYNDECAN 1;

ARTICLE; BREAST CARCINOMA; CANCER CELL CULTURE; CARCINOMA CELL; CELL ADHESION; CELL GROWTH; CELL INVASION; CELL MIGRATION; CELL MOTILITY; CELL STRUCTURE; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FIBER; FIBROBLAST; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; STROMA;

EID: 79251500680     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2010.11.039     Document Type: Article

References (62)

1. Bauer G: Elimination of transformed cells by normal cells: a novel concept for the control of carcinogenesis. Histol Histopathol 1996, 11:237-255
2. Kuperwasser C, Chavarria T, Wu M, Magrane G, Gray JW, Carey L, Richardson A, Weinberg RA: Reconstruction of functionally normal and malignant human breast tissues in mice. Proc Natl Acad Sci U S A 2004, 101:4966-4971 (Pubitemid 38469186)
3. Barsky SH, Green WR, Grotendorst GR, Liotta LA: Desmoplastic breast carcinoma as a source of human myofibroblasts. Am J Pathol 1984, 115:329-333
4. Schor SL, Ellis IR, Jones SJ, Baillie R, Seneviratne K, Clausen J, Motegi K, Vojtesek B, Kankova K, Furrie E, Sales MJ, Schor AM, Kay RA: Migration-stimulating factor: a genetically truncated onco-fetal fibronectin isoform expressed by carcinoma and tumor-associated stromal cells. Cancer Res 2003, 63:8827-8836
5. Tuxhorn JA, Ayala GE, Smith MJ, Smith VC, Dang TD, Rowley DR: Reactive stroma in human prostate cancer: induction of myofibroblast phenotype and extracellular matrix remodeling. Clin Cancer Res 2002, 8:2912-2923
6. Provenzano PP, Eliceiri KW, Campbell JM, Inman DR, White JG, Keely PJ: Collagen reorganization at the tumor-stromal interface facilitates local invasion. BMC Med 2006, 4:38
7. Provenzano PP, Inman DR, Eliceiri KW, Knittel JG, Yan L, Rueden CT, White JG, Keely PJ: Collagen density promotes mammary tumor initiation and progression. BMC Med 2008, 6:11
8. Lopes CC, Dietrich CP, Nader HB: Specific structural features of syndecans and heparan sulfate chains are needed for cell signaling. Braz J Med Biol Res 2006, 39:157-167
9. Tkachenko E, Rhodes JM, Simons M: Syndecans: new kids on the signaling block. Circ Res 2005, 96:488-500
10. Zimmermann P, David G: The syndecans, tuners of transmembrane signaling. FASEB J 1999, 13 Suppl:S9-S100
11. Klass CM, Couchman JR, Woods A: Control of extracellular matrix assembly by syndecan-2 proteoglycan. J Cell Sci 2000, 113(Pt 3):493-506 (Pubitemid 30116655)
12. Saoncella S, Echtermeyer F, Denhez F, Nowlen JK, Mosher DF, Robinson SD, Hynes RO, Goetinck PF: Syndecan-4 signals cooperatively with integrins in a Rho-dependent manner in the assembly of focal adhesions and actin stress fibers. Proc Natl Acad Sci U S A 1999, 96:2805-2810
13. Wilcox-Adelman SA, Denhez F, Goetinck PF: Syndecan-4 modulates focal adhesion kinase phosphorylation. J Biol Chem 2002, 277:32970-32977
14. Ilic D, Kovacic B, Johkura K, Schlaepfer DD, Tomasevic N, Han Q, Kim JB, Howerton K, Baumbusch C, Ogiwara N, Streblow DN, Nelson JA, Dazin P, Shino Y, Sasaki K, Damsky CH: FAK promotes organization of fibronectin matrix and fibrillar adhesions. J Cell Sci 2004, 117:177-187
15. Wierzbicka-Patynowski I, Schwarzbauer JE: Regulatory role for SRC and phosphatidylinositol 3-kinase in initiation of fibronectin matrix assembly. J Biol Chem 2002, 277:19703-19708 (Pubitemid 34967486)
16. Sanderson RD, Hinkes MT, Bernfield M: Syndecan-1, a cell-surface proteoglycan, changes in size and abundance when keratinocytes stratify. J Invest Dermatol 1992, 99:390-396
17. Maeda T, Alexander CM, Friedl A: Induction of syndecan-1 expression in stromal fibroblasts promotes proliferation of human breast cancer cells. Cancer Res 2004, 64:612-621
18. Stanley MJ, Stanley MW, Sanderson RD, Zera R: Syndecan-1 expression is induced in the stroma of infiltrating breast carcinoma. Am J Clin Pathol 1999, 112:377-383
19. Su G, Blaine SA, Qiao D, Friedl A: Shedding of syndecan-1 by stromal fibroblasts stimulates human breast cancer cell proliferation via FGF2 activation. J Biol Chem 2007, 282:14906-14915
20. Maeda T, Desouky J, Friedl A: Syndecan-1 expression by stromal fibroblasts promotes breast carcinoma growth in vivo and stimulates tumor angiogenesis. Oncogene 2006, 25:1408-1412
21. Harvey JM, Clark GM, Osborne CK, Allred DC: Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer. J Clin Oncol 1999, 17:1474-1481
22. Cukierman E: Cell migration analyses within fibroblast-derived 3-D matrices. Methods Mol Biol 2005, 294:79-93
23. Cukierman E: Preparation of Extracellular Matrices Produced by Cultured Fibroblasts. Edited by JS Bonifacino, M Dasso, J Lippincott-Schwartz, JB Harford, KM Yamada. New York, John K. Wiley & Sons, 2002, pp 10.19.11-10.19.14
24. Bernard A, Delamarche E, Schmid H, Michel B, Bosshard HR, Biebuyck H: Printing patterns of proteins. Langmuir 1998, 14:2225-2229
25. Baba F, Swartz K, van Buren R, Eickhoff J, Zhang Y, Wolberg W, Friedl A: Syndecan-1 and syndecan-4 are overexpressed in an estrogen receptor-negative, highly proliferative breast carcinoma subtype. Breast Cancer Res Treat 2006, 98:91-98
26. Bauer M, Eickhoff JC, Gould MN, Mundhenke C, Maass N, Friedl A: Neutrophil gelatinase-associated lipocalin (NGAL) is a predictor of poor prognosis in human primary breast cancer. Breast Cancer Res Treat 2008, 108:389-397
27. Junqueira LC, Bignolas G, Brentani RR: Picrosirius staining plus polarization microscopy, a specific method for collagen detection in tissue sections. Histochem J 1979, 11:447-455
28. Amatangelo MD, Bassi DE, Klein-Szanto AJ, Cukierman E: Stroma-derived three-dimensional matrices are necessary and sufficient to promote desmoplastic differentiation of normal fibroblasts. Am J Pathol 2005, 167:475-488
29. Cukierman E: Preparation of extracellular matrices produced by cultured fibroblasts. Edited by JB Harford and KM Yamada. Philadelphia, Lippincott-Schwartz, 2002, pp 10.19.11-10.19.14
30. Weigelt B, Bissell MJ: Unraveling the microenvironmental influences on the normal mammary gland and breast cancer. Semin Cancer Biol 2008, 18:311-321
31. Nelson CM, Bissell MJ: Of extracellular matrix, scaffolds, and signaling: tissue architecture regulates development, homeostasis, and cancer. Annu Rev Cell Dev Biol 2006, 22:287-309
32. Thompson EW, Paik S, Brunner N, Sommers CL, Zugmaier G, Clarke R, Shima TB, Torri J, Donahue S, Lippman ME, Martin GR, Dickson RB: Association of increased basement membrane invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell lines. J Cell Physiol 1992, 150:534-544
33. Wu C, Keivens VM, O'Toole TE, McDonald JA, Ginsberg MH: Integrin activation and cytoskeletal interaction are essential for the assembly of a fibronectin matrix. Cell 1995, 83:715-724
34. Wilhelm O, Hafter R, Coppenrath E, Pflanz MA, Schmitt M, Babic R, Linke R, Gossner W, Graeff H: Fibrin-fibronectin compounds in human ovarian tumor ascites and their possible relation to the tumor stroma. Cancer Res 1988, 48:3507-3514
35. Moro L, Colombi M, Molinari Tosatti MP, Barlati S: Study of fibronectin and mRNA in human laryngeal and ectocervical carcinomas by in situ hybridization and image analysis. Int J Cancer 1992, 51:692-697
36. DiMilla PA, Stone JA, Quinn JA, Albelda SM, Lauffenburger DA: Maximal migration of human smooth muscle cells on fibronectin and type IV collagen occurs at an intermediate attachment strength. J Cell Biol 1993, 122:729-737
37. Goodman SL, Risse G, von der Mark K: The E8 subfragment of laminin promotes locomotion of myoblasts over extracellular matrix. J Cell Biol 1989, 109:799-809 (Pubitemid 19197038)
38. Palecek SP, Loftus JC, Ginsberg MH, Lauffenburger DA, Horwitz AF: Integrin-ligand binding properties govern cell migration speed through cell-substratum adhesiveness. Nature 1997, 385:537-540
39. Sottile J, Hocking DC: Fibronectin polymerization regulates the composition and stability of extracellular matrix fibrils and cell-matrix adhesions. Mol Biol Cell 2002, 13:3546-3559
40. Velling T, Risteli J, Wennerberg K, Mosher DF, Johansson S: Polymerization of type I and III collagens is dependent on fibronectin and enhanced by integrins alpha 11beta 1 and alpha 2beta 1. J Biol Chem 2002, 277:37377-37381
41. Wierzbicka-Patynowski I, Schwarzbauer JE: The ins and outs of fibronectin matrix assembly. J Cell Sci 2003, 116:3269-3276
42. Mao Y, Schwarzbauer JE: Fibronectin fibrillogenesis, a cell-mediated matrix assembly process. Matrix Biol 2005, 24:389-399
43. Beauvais DM, Burbach BJ, Rapraeger AC: The syndecan-1 ectodomain regulates alphavbeta3 integrin activity in human mammary carcinoma cells. J Cell Biol 2004, 167:171-181
44. McQuade KJ, Beauvais DM, Burbach BJ, Rapraeger AC: Syndecan-1 regulates alphavbeta5 integrin activity in B82L fibroblasts. J Cell Sci 2006, 119:2445-2456
45. Ogawa T, Tsubota Y, Hashimoto J, Kariya Y, Miyazaki K: The short arm of laminin gamma2 chain of laminin-5 (laminin-332) binds syndecan-1 and regulates cellular adhesion and migration by suppressing phosphorylation of integrin beta4 chain. Mol Biol Cell 2007, 18:1621-1633 (Pubitemid 46717545)
46. Beauvais DM, Ell BJ, McWhorter AR, Rapraeger AC: Syndecan-1 regulates alphavbeta3 and alphavbeta5 integrin activation during angiogenesis and is blocked by synstatin, a novel peptide inhibitor. J Exp Med 2009, 206:691-705
47. Fogerty FJ, Akiyama SK, Yamada KM, Mosher DF: Inhibition of binding of fibronectin to matrix assembly sites by anti-integrin (alpha 5 beta 1) antibodies. J Cell Biol 1990, 111:699-708
48. Wu C, Bauer JS, Juliano RL, McDonald JA: The alpha 5 beta 1 integrin fibronectin receptor, but not the alpha 5 cytoplasmic domain, functions in an early and essential step in fibronectin matrix assembly. J Biol Chem 1993, 268:21883-21888
49. Yang JT, Hynes RO: Fibronectin receptor functions in embryonic cells deficient in alpha 5 beta 1 integrin can be replaced by alpha V integrins. Mol Biol Cell 1996, 7:1737-1748
50. Wu C, Hughes PE, Ginsberg MH, McDonald JA: Identification of a new biological function for the integrin alpha v beta 3: initiation of fibronectin matrix assembly. Cell Adhes Commun 1996, 4:149-158 (Pubitemid 26400745)
51. Wennerberg K, Lohikangas L, Gullberg D, Pfaff M, Johansson S, Fassler R: Beta 1 integrin-dependent and -independent polymerization of fibronectin. J Cell Biol 1996, 132:227-238
52. Sechler JL, Cumiskey AM, Gazzola DM, Schwarzbauer JE: A novel RGD-independent fibronectin assembly pathway initiated by alpha4beta1 integrin binding to the alternatively spliced V region. J Cell Sci 2000, 113( Pt 8):1491-1498
53. Johnson KJ, Sage H, Briscoe G, Erickson HP: The compact conformation of fibronectin is determined by intramolecular ionic interactions. J Biol Chem 1999, 274:15473-15479
54. Hynes RO: The dynamic dialogue between cells and matrices: implications of fibronectin's elasticity. Proc Natl Acad Sci U S A 1999, 96:2588-2590
55. Tumova S, Woods A, Couchman JR: Heparan sulfate chains from glypican and syndecans bind the Hep II domain of fibronectin similarly despite minor structural differences. J Biol Chem 2000, 275:9410-9417
56. Wozniak MA, Desai R, Solski PA, Der CJ, Keely PJ: ROCK-generated contractility regulates breast epithelial cell differentiation in response to the physical properties of a three-dimensional collagen matrix. J Cell Biol 2003, 163:583-595
57. Paszek MJ, Zahir N, Johnson KR, Lakins JN, Rozenberg GI, Gefen A, Reinhart-King CA, Margulies SS, Dembo M, Boettiger D, Hammer DA, Weaver VM: Tensional homeostasis and the malignant phenotype. Cancer Cell 2005, 8:241-254
58. Green JA, Yamada KM: Three-dimensional microenvironments modulate fibroblast signaling responses. Adv Drug Deliv Rev 2007, 59: 1293-1298
59. Pankov R, Endo Y, Even-Ram S, Araki M, Clark K, Cukierman E, Matsumoto K, Yamada KM: A Rac switch regulates random versus directionally persistent cell migration. J Cell Biol 2005, 170:793-802
60. Vicente-Manzanares M, Webb DJ, Horwitz AR: Cell migration at a glance. J Cell Sci 2005, 118:4917-4919
61. Ridley AJ, Schwartz MA, Burridge K, Firtel RA, Ginsberg MH, Borisy G, Parsons JT, Horwitz AR: Cell migration: integrating signals from front to back. Science 2003, 302:1704-1709
62. Zijlstra A, Lewis J, Degryse B, Stuhlmann H, Quigley JP: The inhibition of tumor cell intravasation and subsequent metastasis via regulation of in vivo tumor cell motility by the tetraspanin CD151. Cancer Cell 2008, 13:221-234 (Pubitemid 351318371)